Sejong Medical Co., Ltd.

Informe acción KOSDAQ:A258830

Capitalización de mercado: ₩22.8b

Sejong Medical Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Byungsung Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO1.3yrs
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates

Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Mar 24
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Mar 02
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

Feb 11
Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Jan 27
We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Jan 12
Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Dec 25
Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

Dec 23
Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

Dec 08
These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

Nov 19
The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

CEO

Byungsung Kim (53 yo)

1.3yrs

Permanencia

Byungsung Kim serves as Chief Executive Officer at Sejong Medical Co., Ltd. since 2023. Byungsung Kim served as Representative Director at Sejong Medical Co., Ltd.